Saturday, November 1, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Automotive & E-Mobility

Cooper-Standard Shares Plunge on Disappointing Earnings Report

Felix Baarz by Felix Baarz
November 1, 2025
in Automotive & E-Mobility, Earnings, Industrial
0
Cooper-Standard Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Cooper-Standard Holdings Inc. witnessed a severe selloff in its stock price following the release of unexpectedly poor quarterly results. The automotive supplier’s Thursday earnings report fell substantially short of market expectations, triggering an immediate negative reaction from investors.

Financial Performance Misses the Mark

The company reported a net loss of $7.6 million for the third quarter of 2025, translating to a loss of $0.43 per share. On an adjusted basis, which excludes special items, the loss stood at $0.24 per share. This performance represented a significant deviation from analyst projections, which had anticipated earnings between $0.38 and $0.50 per share. The variance from expectations amounted to a negative surprise of $0.74 per share.

Revenue figures also disappointed, coming in at $695.5 million, slightly below the consensus estimate of $698.83 million. Investor response was swift and decisive. When trading commenced on Friday, the stock opened at $36.17 and proceeded to decline by 6.2 percent. This downward movement reduced the company’s market capitalization to $637.71 million.

Operational Improvements Provide Silver Lining

Despite the overall disappointing financial outcome, several operational metrics showed notable improvement. The gross margin expanded by 140 basis points to reach 12.5 percent of sales. Adjusted EBITDA demonstrated strong growth, climbing 15.6 percent to $53.3 million.

Additional positive operational indicators included:
* Adjusted net loss: $4.4 million
* Adjusted EBITDA: $53.3 million
* Operating cash flow: $38.6 million (an increase of $10.8 million)
* Free cash flow: $27.4 million (an increase of $10.5 million)

Should investors sell immediately? Or is it worth buying Cooper-Standard?

These figures suggest that the company’s focus on cost control and operational efficiency is yielding tangible benefits.

Divergent Views from Market Analysts

A key area of focus for Cooper-Standard is its ability to secure new business. During Q3, the company secured new contracts valued at $96 million, predominantly for electric and hybrid vehicle applications. Year-to-date, the total contract value has reached nearly $229 million.

Market experts, however, remain divided on the company’s prospects. The analytical community displays a wide range of opinions:
* Stifel Nicolaus has raised its price target to $41 and maintains a “Buy” recommendation.
* GuruFocus, in contrast, calculates a fair value of just $14.40 per share.
* The average price target among analysts sits at $26.50, accompanied by a “Moderate Buy” recommendation.

Future Outlook and Financial Position

Looking ahead to the full 2025 fiscal year, Cooper-Standard management has provided revenue guidance in the range of $2.68 billion to $2.72 billion. Interestingly, analyst earnings expectations have improved markedly over the past 90 days, shifting from an anticipated loss of $0.64 per share to a projected small profit of $0.07 per share.

The company maintains a solid liquidity position, with cash and cash equivalents of $147.6 million and total liquidity of $313.5 million, providing adequate financial flexibility. The critical question facing investors remains whether Cooper-Standard can leverage these strengths to achieve the long-awaited turnaround in its financial performance.

Ad

Cooper-Standard Stock: Buy or Sell?! New Cooper-Standard Analysis from November 1 delivers the answer:

The latest Cooper-Standard figures speak for themselves: Urgent action needed for Cooper-Standard investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 1.

Cooper-Standard: Buy or sell? Read more here...

Tags: Cooper-Standard
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

DroneShield Stock
Defense & Aerospace

DroneShield Stock Analysis: Assessing the Growth Trajectory After Record Quarter

November 1, 2025
Vera Therapeutics Stock
Analysis

Pivotal Week Ahead for Vera Therapeutics Investors

November 1, 2025
Redcare Pharmacy Stock
Analysis

Redcare Pharmacy Shares Tumble Despite Record Performance

November 1, 2025
Next Post
Flushing Stock

Flushing Financial Delivers Stellar Third Quarter Performance

Weave Communications Stock

Weave Communications: Strong Growth Meets Market Skepticism

Alico Stock

Alico's Pivotal Transformation: Navigating Crisis Through Strategic Overhaul

Recommended

Robinhood Stock

Robinhood Shares Surge Toward Record High on Index Inclusion News

1 month ago
Ocugen Stock

Ocugen’s Divergent Paths: Analyst Optimism Meets Merger Setback

1 month ago
DoubleVerify Holdings Stock

DoubleVerify’s Meta Integration: A Strategic Move in Digital Advertising

2 months ago
Toyota Stock

Toyota Stock: Tariff Woes Slash Profits Despite Sales Growth

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Redcare Pharmacy Shares Tumble Despite Record Performance

C3.ai Shares Plunge Amidst Financial Turmoil and Leadership Shakeup

High-Yield Opportunity: Outfront Media Shares Offer 7% Dividend

Insider Selling Spree Rattles MACOM Investors Ahead of Earnings

Unum Shares Face Pressure Ahead of Quarterly Earnings Release

Healthcare REIT Faces Critical Earnings Test with Major Upside Potential

Trending

DroneShield Stock
Defense & Aerospace

DroneShield Stock Analysis: Assessing the Growth Trajectory After Record Quarter

by Andreas Sommer
November 1, 2025
0

The Australian counter-drone technology firm DroneShield has reported quarterly results that have captured significant market attention. A...

Bionxt Solutions Stock

Bionxt Solutions Strengthens Market Position with Patent Milestone and Financial Improvements

November 1, 2025
Vera Therapeutics Stock

Pivotal Week Ahead for Vera Therapeutics Investors

November 1, 2025
Redcare Pharmacy Stock

Redcare Pharmacy Shares Tumble Despite Record Performance

November 1, 2025
C3.ai Stock

C3.ai Shares Plunge Amidst Financial Turmoil and Leadership Shakeup

November 1, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • DroneShield Stock Analysis: Assessing the Growth Trajectory After Record Quarter
  • Bionxt Solutions Strengthens Market Position with Patent Milestone and Financial Improvements
  • Pivotal Week Ahead for Vera Therapeutics Investors

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com